Simone Chevalier

Simone Chevalier

UNVERIFIED PROFILE

Are you Simone Chevalier?   Register this Author

Register author
Simone Chevalier

Simone Chevalier

Publications by authors named "Simone Chevalier"

Are you Simone Chevalier?   Register this Author

41Publications

752Reads

12Profile Views

Improving ultrasound-based prostate volume estimation.

BMC Urol 2019 Jul 24;19(1):68. Epub 2019 Jul 24.

Urologic Oncology Research Group, Cancer Research Program, Research Institute (RI) of McGill University Health Center (MUHC), Glen Campus, E M2.2210, 1001 Blvd Décarie, Montréal, Qc, H4A 3J1, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s12894-019-0492-2DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6657110PMC
July 2019

A Comprehensive Analysis of Steroid Hormones and Progression of Localized High-Risk Prostate Cancer.

Cancer Epidemiol Biomarkers Prev 2019 04 7;28(4):701-706. Epub 2019 Feb 7.

CHU de Québec Research Centre and Faculty of Pharmacy, Laval University, Québec, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1055-9965.EPI-18-1002DOI Listing
April 2019

Psychosocial adjustment to a prostate cancer diagnosis in a cohort of radical prostatectomy patients in Quebec, Canada.

Psychooncology 2019 04 27;28(4):839-846. Epub 2019 Feb 27.

Division of Urology, Department of Surgery, McGill University Health Centre, Montreal, Quebec, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/pon.5031DOI Listing
April 2019

The combination of PTEN deletion and 16p13.3 gain in prostate cancer provides additional prognostic information in patients treated with radical prostatectomy.

Mod Pathol 2019 01 23;32(1):128-138. Epub 2018 Aug 23.

Division of Urology, Department of Surgery, McGill University and the Research Institute of the McGill University Health Centre, Montreal, QC, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41379-018-0107-6DOI Listing
January 2019

Describing perspectives of health care professionals on active surveillance for the management of prostate cancer.

BMC Health Serv Res 2018 06 8;18(1):430. Epub 2018 Jun 8.

Institut du cancer de Montréal and Centre de recherche du Centre hospitalier de l'Université de Montréal, 900, St Denis St, Montréal, QC, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s12913-018-3273-9DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5994022PMC
June 2018

Genomic Gain of 16p13.3 in Prostate Cancer Predicts Poor Clinical Outcome after Surgical Intervention.

Mol Cancer Res 2018 01 9;16(1):115-123. Epub 2017 Oct 9.

Department of Surgery, Division of Urology, McGill University and the Research Institute of the McGill University Health Centre, Montréal, Québec, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1541-7786.MCR-17-0270DOI Listing
January 2018

Asporin is a stromally expressed marker associated with prostate cancer progression.

Br J Cancer 2017 Mar 2;116(6):775-784. Epub 2017 Feb 2.

Department of Surgery, Division of Urology, McGill University and the Cancer Research Program of the Research Institute of McGill University Health Centre, Montreal, Quebec H4A 3J1, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/bjc.2017.15DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5355923PMC
March 2017

A Simple Variable Number of Tandem Repeat-Based Genotyping Strategy for the Detection of Handling Errors and Validation of Sample Identity in Biobanks.

Biopreserv Biobank 2016 Oct 21;14(5):383-389. Epub 2016 Jun 21.

1 McGill University Health Centre and Research Institute , Montréal, Canada .

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1089/bio.2015.0113DOI Listing
October 2016

Management of localized and advanced prostate cancer in Canada: A lifetime cost and quality-adjusted life-year analysis.

Cancer 2016 Apr 1;122(7):1085-96. Epub 2016 Feb 1.

Department of Urology, McGill University, Montreal, Quebec, Canada.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1002/cncr.29892
Publisher Site
http://dx.doi.org/10.1002/cncr.29892DOI Listing
April 2016

The dog prostate cancer (DPC-1) model: a reliable tool for molecular imaging of prostate tumors and metastases.

EJNMMI Res 2015 Dec 30;5(1):77. Epub 2015 Dec 30.

Urologic Oncology Research Group, Division of Urology, Department of Surgery, McGill University, and Research Institute (RI) of McGill University Health Centre (MUHC), 1001 Boulevard Décarie, Montréal, QC, H4A 3J1, Canada.

View Article

Download full-text PDF

Source
http://www.ejnmmires.com/content/5/1/77
Publisher Site
http://dx.doi.org/10.1186/s13550-015-0155-6DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4695479PMC
December 2015

Electrochemical red-ox therapy of prostate cancer in nude mice.

Bioelectrochemistry 2015 Aug 19;104:1-9. Epub 2014 Dec 19.

Urologic-Oncology Research Laboratory, McGill University Health Center Research Institute, Montreal, Quebec, Canada; Division of Urology, Dept. of Surgery, McGill University, Montreal, Quebec, Canada. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bioelechem.2014.12.004DOI Listing
August 2015

Clinical management and burden of prostate cancer: a Markov Monte Carlo model.

PLoS One 2014 4;9(12):e113432. Epub 2014 Dec 4.

Department of Surgery, Division of Urology, McGill University, Montreal, Quebec, Canada; Research Institute of McGill University Health Center, Montreal, Quebec, Canada.

View Article

Download full-text PDF

Source
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0113432PLOS
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4256380PMC
July 2015

The Fer tyrosine kinase acts as a downstream interleukin-6 effector of androgen receptor activation in prostate cancer.

Mol Cell Endocrinol 2013 Dec 30;381(1-2):140-9. Epub 2013 Jul 30.

Urologic Oncology Research Group, Departments of Surgery (Urology Division), Medicine, and Oncology, McGill University Health Center (MUHC) Research Institute (RI), Canada.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S03037207130031
Publisher Site
http://dx.doi.org/10.1016/j.mce.2013.07.017DOI Listing
December 2013

Endoscopic vascular targeted photodynamic therapy with the photosensitizer WST11 for benign prostatic hyperplasia in the preclinical dog model.

J Urol 2013 Nov 13;190(5):1946-53. Epub 2013 May 13.

Urologic Oncology Research Group, McGill University Health Centre-Research Institute, Montreal, Quebec, Canada. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.juro.2013.05.014DOI Listing
November 2013

Simultaneous quantification of mitochondrial DNA damage and copy number in circulating blood: a sensitive approach to systemic oxidative stress.

Biomed Res Int 2013 27;2013:157547. Epub 2012 Dec 27.

Department of Surgery/Division of Urology, The Research Institute of McGill University Health Center, 1650 Cedar Avenue, Room R1.107, Montreal, QC, Canada H3G 1A4.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1155/2013/157547DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3591215PMC
September 2013

The 16p13.3 (PDPK1) Genomic Gain in Prostate Cancer: A Potential Role in Disease Progression.

Transl Oncol 2012 Dec 1;5(6):453-60. Epub 2012 Dec 1.

Department of Surgery, Division of Urology, McGill University and the Research Institute of the McGill University Health Centre (RI MUHC), Montreal, Quebec, Canada.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3568696PMC
http://dx.doi.org/10.1593/tlo.12286DOI Listing
December 2012

PTEN genomic deletion predicts prostate cancer recurrence and is associated with low AR expression and transcriptional activity.

BMC Cancer 2012 Nov 22;12:543. Epub 2012 Nov 22.

Department of Surgery, Division of Urology, McGill University and the Research Institute of the McGill University Health Centre(RI-MUHC), Montreal H3G 1A4 QC, Canada.

View Article

Download full-text PDF

Source
http://bmccancer.biomedcentral.com/articles/10.1186/1471-240
Publisher Site
http://dx.doi.org/10.1186/1471-2407-12-543DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3527151PMC
November 2012

Refining the orthotopic dog prostate cancer (DPC)-1 model to better bridge the gap between rodents and men.

Prostate 2012 May 31;72(7):752-61. Epub 2011 Aug 31.

Department of Surgery (Urology), McGill University Health Centre and Research Institute, Montreal, Quebec, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/pros.21479DOI Listing
May 2012

Mitochondrial DNA damage is sensitive to exogenous H(2)O(2) but independent of cellular ROS production in prostate cancer cells.

Mutat Res 2011 Nov 5;716(1-2):40-50. Epub 2011 Aug 5.

Department of Surgery, McGill University Health Center, Montreal, Quebec, Canada.

View Article

Download full-text PDF

Source
http://linkinghub.elsevier.com/retrieve/pii/S002751071100214
Publisher Site
http://dx.doi.org/10.1016/j.mrfmmm.2011.07.019DOI Listing
November 2011

Preclinical study of the novel vascular occluding agent, WST11, for photodynamic therapy of the canine prostate.

J Urol 2011 Jul 20;186(1):302-9. Epub 2011 May 20.

Urologic Oncology Research Group, Research Institute, McGill University Health Center, Montreal, Quebec, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.juro.2011.03.039DOI Listing
July 2011

Identification of distinctive patterns of USP19-mediated growth regulation in normal and malignant cells.

PLoS One 2011 Jan 17;6(1):e15936. Epub 2011 Jan 17.

Polypeptide Laboratory, Department of Medicine, McGill University Health Centre Research Institute, McGill University, Montreal, Quebec, Canada.

View Article

Download full-text PDF

Source
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0015936PLOS
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3022023PMC
January 2011

Inhibition of mammalian target of rapamycin as a therapeutic strategy in the management of bladder cancer.

Cancer Biol Ther 2009 Dec 2;8(24):2339-47. Epub 2009 Dec 2.

Division of Urology, McGill University Health Center, Montreal, QC, CA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4161/cbt.8.24.9987DOI Listing
December 2009

Botulinum toxin type A inhibits the growth of LNCaP human prostate cancer cells in vitro and in vivo.

Prostate 2009 Aug;69(11):1143-50

Department of Urology, Hôpital Sainte Marguerite, Assistance Publique-Hôpitaux de Marseille, Université de la Méditérranée, Marseille, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/pros.20958DOI Listing
August 2009

Focal adhesion kinase is required for bombesin-induced prostate cancer cell motility.

Mol Cell Endocrinol 2005 May 19;235(1-2):51-61. Epub 2005 Mar 19.

Urologic Oncology Research Group, Urology Division, Departmentof Surgery, McGill University Health Center (MUHC) Research Institute, Montreal, QC, Canada H3G 1A4.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.mce.2004.06.014DOI Listing
May 2005

Expression of vascular endothelial growth factor-A in human lymph node metastases of prostate cancer.

Can J Urol 2004 Feb;11(1):2146-50

Urologic Oncology Research Group, Department of Surgery, Urology Division, McGill University.

View Article

Download full-text PDF

Source
February 2004

Androgen ablation promotes neuroendocrine cell differentiation in dog and human prostate.

Prostate 2002 May;51(2):117-25

Urologic Oncology Research Group, Department of Surgery, Urology Division, McGill University Health Center, Montreal, Quebec, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/pros.10066DOI Listing
May 2002